From USFDA
Zydus Cadila has received tentative approval from USFDA to market Tadalafil Tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg. The drug is indicated in the treatment of erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
